Cargando…

The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing

Human brain is undoubtedly the most complex organ in the body. Thus, it is difficult to develop adequate and at the same time human relevant test systems and models to cover the aspects of brain homeostasis and even more challenging to address brain development. Animal tests for Developmental Neurot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogberg, Helena T., Smirnova, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915853/
https://www.ncbi.nlm.nih.gov/pubmed/35295222
http://dx.doi.org/10.3389/ftox.2022.808620
_version_ 1784668147107758080
author Hogberg, Helena T.
Smirnova, Lena
author_facet Hogberg, Helena T.
Smirnova, Lena
author_sort Hogberg, Helena T.
collection PubMed
description Human brain is undoubtedly the most complex organ in the body. Thus, it is difficult to develop adequate and at the same time human relevant test systems and models to cover the aspects of brain homeostasis and even more challenging to address brain development. Animal tests for Developmental Neurotoxicity (DNT) have been devised, but because of complex underlying mechanisms of neural development, and interspecies differences, there are many limitations of animal-based approaches. The high costs, high number of animals used per test and technical difficulties of these tests are prohibitive for routine DNT chemical screening. Therefore, many potential DNT chemicals remain unidentified. New approach methodologies (NAMs) are needed to change this. Experts in the field have recommended the use of a battery of human in vitro tests to be used for the initial prioritization of high-risk environmental chemicals for DNT testing. Microphysiological systems (MPS) of the brain mimic the in vivo counterpart in terms of cellular composition, recapitulation of regional architecture and functionality. These systems amendable to use in a DNT test battery with promising features such as (i) complexity, (ii) closer recapitulation of in vivo response and (iii) possibility to multiplex many assays in one test system, which can increase throughput and predictivity for human health. The resent progress in 3D brain MPS research, advantages, limitations and future perspectives are discussed in this review.
format Online
Article
Text
id pubmed-8915853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89158532022-03-15 The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing Hogberg, Helena T. Smirnova, Lena Front Toxicol Toxicology Human brain is undoubtedly the most complex organ in the body. Thus, it is difficult to develop adequate and at the same time human relevant test systems and models to cover the aspects of brain homeostasis and even more challenging to address brain development. Animal tests for Developmental Neurotoxicity (DNT) have been devised, but because of complex underlying mechanisms of neural development, and interspecies differences, there are many limitations of animal-based approaches. The high costs, high number of animals used per test and technical difficulties of these tests are prohibitive for routine DNT chemical screening. Therefore, many potential DNT chemicals remain unidentified. New approach methodologies (NAMs) are needed to change this. Experts in the field have recommended the use of a battery of human in vitro tests to be used for the initial prioritization of high-risk environmental chemicals for DNT testing. Microphysiological systems (MPS) of the brain mimic the in vivo counterpart in terms of cellular composition, recapitulation of regional architecture and functionality. These systems amendable to use in a DNT test battery with promising features such as (i) complexity, (ii) closer recapitulation of in vivo response and (iii) possibility to multiplex many assays in one test system, which can increase throughput and predictivity for human health. The resent progress in 3D brain MPS research, advantages, limitations and future perspectives are discussed in this review. Frontiers Media S.A. 2022-01-27 /pmc/articles/PMC8915853/ /pubmed/35295222 http://dx.doi.org/10.3389/ftox.2022.808620 Text en Copyright © 2022 Hogberg and Smirnova. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Toxicology
Hogberg, Helena T.
Smirnova, Lena
The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title_full The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title_fullStr The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title_full_unstemmed The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title_short The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
title_sort future of 3d brain cultures in developmental neurotoxicity testing
topic Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915853/
https://www.ncbi.nlm.nih.gov/pubmed/35295222
http://dx.doi.org/10.3389/ftox.2022.808620
work_keys_str_mv AT hogberghelenat thefutureof3dbrainculturesindevelopmentalneurotoxicitytesting
AT smirnovalena thefutureof3dbrainculturesindevelopmentalneurotoxicitytesting
AT hogberghelenat futureof3dbrainculturesindevelopmentalneurotoxicitytesting
AT smirnovalena futureof3dbrainculturesindevelopmentalneurotoxicitytesting